Skip to main content

Nanotherapeutics in Cancer Vaccination and Challenges

  • 1st Edition - March 3, 2022
  • Editors: Mahfoozur Rahman, Sarwar Beg, Waleed H Almalki, Nabil A. Alhakamy, Hani Choudhry
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 1 2 - 8 2 3 6 8 6 - 4
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 8 2 3 6 8 7 - 1

Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective… Read more

Nanotherapeutics in Cancer Vaccination and Challenges

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.

Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy.